StockData
Omada Health, Inc. logo

Omada Health, Inc. (OMDA) stock

OMDANasdaqServices-Health ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30102% above fair value
$14.08−0.41 (-2.83%)

Close on Nov 17, 2026Market cap $861.93MP/E –Yield –

Omada Health r&d expenses

Research and development expenses are spending on new products and technology.

Omada Health's R&D Expenses for the twelve months ending Jun 30, 2026 was $49.18M, up 33.4% year over year. For fiscal 2025 it was $40.68M, up 13.3% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$40.68M+13.3%
FY2024Dec 31, 2024$35.92M+6.5%
FY2023Dec 31, 2023$33.74M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$14.63M+45.9%
Q1 FY2026Mar 31, 2026$12.70M+44.2%
Q4 FY2025Dec 31, 2025$11.55M+25.7%
Q3 FY2025Sep 30, 2025$10.30M+16.4%
Q2 FY2025Jun 30, 2025$10.02M+11.5%
Q1 FY2025Mar 31, 2025$8.81M–
Q4 FY2024Dec 31, 2024$9.19M–
Q3 FY2024Sep 30, 2024$8.85M–
Q2 FY2024Jun 30, 2024$8.99M–

More Omada Health figures

See a number that looks wrong?